Microbix Biosystems Inc. (MBX.TO)
| Previous Close | 0.3550 |
| Open | 0.3550 |
| Bid | 0.3450 x 0 |
| Ask | 0.3550 x 0 |
| Day's Range | 0.3450 - 0.3550 |
| 52 Week Range | 0.2300 - 0.4500 |
| Volume | |
| Avg. Volume | 42,825 |
| Market Cap | 47.847M |
| Beta (5Y Monthly) | 0.34 |
| PE Ratio (TTM) | 8.75 |
| EPS (TTM) | 0.0400 |
| Earnings Date | Dec 19, 2024 - Dec 23, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Sept 02, 1999 |
| 1y Target Est | N/A |
- Baystreet
Stocks in play: Microbix Biosystems Inc.
Announces that it has upgraded its European Union regulatory compliance for its diagnostic assay quality ...
GlobeNewswireMicrobix Achieves Essential EU Regulatory Accreditations
IVDR Compliance and CE Certifications for REDx™ QAPsMISSISSAUGA, Ontario, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has upgraded its European Union (“EU”) regulatory compliance for its diagnostic assay quality assessment products (“QAPs™”). Specifically, Microbix has obtained recognition of its quality management system compliance with the EU In Vitro Diagnostics Regulat
- GlobeNewswire
Microbix Presenting at Muskoka Capital Conference
Meetings with Growth-Oriented Investors, September 27 to 29, 2024MISSISSAUGA, Ontario, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Muskoka Capital Conference, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in Minett, Ontario, September 27 to 29, 2024. Microbix’s CEO, Cameron Groome, wi
